-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Maintains Buy on Imax, Raises Price Target to $42

Benzinga·12/08/2025 13:32:48
Listen to the news
Benchmark analyst Mike Hickey maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $40 to $42.